References
- Baggio L.L., Drucker D.J.: Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132, 2131–2157.
- Bell G.I., Santerre R.F., Mullenbach G.T.: Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 1983, 302, 716–718.
- Berghöfer P., Peterson R.G., Schneider K., Fehmann H.C., Göke B.: Incretin hormone expression in the gut of diabetic mice and rats. Metabolism 1997, 46, 261–267.
- Bojanowska E.: Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): the role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress. Med Sci Monit 2005, 11, 271–278.
- Chomczynski P., Sacchi N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162, 156–159.
- Eissele R., Göke R., Willemer S., Harthus H.P., Vermeer H., Arnold R., Göke B.: Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 1992, 22, 283–291.
- Gallwitz B.: Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes 2016, 23, 23–27.
- Gautier J.F., Choukem J., Girard J.: Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab 2008, 34, 65–72.
- Gilor C., Gilor S., Graves T.K., Borst L.B., Labelle P., Ridge T.K., Santoro D., Dossin O.: Distribution of K and L cells in the feline intestinal tract. Domest Anim Endocrinol 2013, 45, 49–54.
- Halban P.A., Polonsky K.S., Bowden D.W., Hawkins M.A., Ling C., Mather K.J., Powers A.C., Rhodes C.J., Sussel L., Weir G.C.: β-cell failure in type 2 diabetes: Postulated mechanisms and prospects for prevention and treatment. Diabetes Care 2014, 37, 1751–1758.
- Holst J.J., Vilsboll T., Deacon C.F.: The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 2009, 297, 127–136.
- Holst J.J.: Enteroendocrine secretion of gut hormones in diabetes, obesity, and after bariatric surgery. Curr Opin Pharmacol 2013, 13, 983–988.
- Holst J.J.: Glucagon and glucagon-like peptides 1 and 2. Results Probl Cell Differ 2010, 50, 121–135.
- Ito M., Kondo Y., Nakatani A., Hayashi K., Naruse A.: Characterization of low dose streptozotocin-induced progressive diabetes in mice. Environ Toxicol Pharmacol 2001, 9, 71–78.
- Kanitkar M., Bhonde R.: Existence of islet regenerating factors within the pancreas. Rev Diabetes Stud 2004, 1, 185–192.
- Kilimnik G., Kim A., Steiner D.F., Friedman T.C., Hara M.: Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of β-cell regeneration. Islets 2010, 2, 149–155.
- Kjems L.L., Holst J.J., Vølund A., Madsbad S.: The influence of GLP-1 on glucose-stimulated insulin secretion. Effects on β-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 2003, 52, 380–386.
- Klöppel G., Löhr M., Habich K., Oberholzer M., Heitz P.U.: Islet pathology and pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985, 4, 110–125.
- Koral Taşçı S., Gülmez N.: Immunohistochemical distribution of glutathione peroxidase and its gene expression via RT-PCR in the liver tissue of melatonin-administered mice. Turk J Vet Anim Sci 2014, 38, 145–150.
- Lugari L., Dell’Anna C., Ugolotti D., Gnudi A.: Effect of nutrient ingestion on glucagon-like peptide-1-induced insulin secretion in human type 1 and type 2 diabetes. Horm Metab Res 2000, 32, 424–448.
- Mojsov S., Kopczynski M.G., Habener J.F.: Both amidated and nonamidated forms of glucagon-like peptide 1 are synthesized in the rat ıntestine and the pancreas J Biol Chem 1990, 265, 8001–8008.
- Nadkarni P., Chepurny O.G., Holz G.G.: Regulation of glucose homeostasis by GLP-1. Prog Mol Biol Transl Sci 2014, 121, 23–65.
- Nauck M.A., Vardarli I., Deacon C.F., Holst J.J., Meier J.J.: Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011, 54, 10–18.
- Pala L., Mannucci E., Pezzatini A., Ciani S., Sardi J., Raimondi L., Ognibene A., Cappadona A., Vannelli B.G., Rotella C.M.: Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells. Biochem Biophys Res Commun 2003, 310, 28–31.
- Plesner A., Holder J.T., Verchere C.B.: Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes. PLoS ONE 2014, 9, e102843.
- Rydgren T., Börjesson A., Carlsson A., Sandler S.: Elevated glucagon-like peptide-1 plasma levels, as a possible adaptive response, in diabetic NOD mice. BBRC 2012, 423, 583–587.
- Scamuffa N., Calvo F., Seidah N.G., Khatib A.M.: Proprotein convertases: lessons from knockouts. FASEB J 2006, 20, 1954–1963.
- Vignali S., Leiss V., Karl R., Hofmann F., Welling A.: Characterization of voltage-dependent sodium and calcium channels in mouse pancreatic A- and B-cells. J Physiol 2006, 572, 691–706.
- Watanabe T., Nishimura K., Monir M.M., Takemoto C., Hiramatsu K.: Immunoelectron microscopic observation of chicken glucagon-like peptide (GLP)-1-containing cells in tissues derived from thin section, paraffin block and conventional method. J Vet Med Sci 2014, 76, 389–394.
- Williams J.A.: GLP-1. In: The PancreapediaExocrine Pancreas Knowledge Base Ann Arbor, University of Michigan, 2014, pp. 1–14.